CI vs PACB · P/E 2.4, rev $274.90B vs rev $38.4M
Cigna Corp (CI) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. PACB currently screens at market cap $387.1M.
Not investment advice. Open the CI and PACB stock pages for the full models.
Not investment advice.